Practice Guidelines for Transdermal Opioids in Malignant Pain

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.23, 2004-01, pp. : 2629-2638

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of transdermal opioids in patients with malignant pain requires an individualised and aggressive approach

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 10, 2005-10 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Non-Analgesic Effects of Opioids: The Cognitive Effects of Opioids in Chronic Pain of Malignant and Non-Malignant Origin. An Update.

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6116-6122

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Transdermal Opioids: Focus on Transdermal Fentanyl

By Grond S. Radbruch L. Lehmann K.A.

Clinical Pharmacokinetics, Vol. 38, Iss. 1, 2000-01 ,pp. : 59-89

Adis International

Access to resources Recommend Favorite

Opioids in chronic pain

By Przewlocki R. Przewlocka B.

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 79-91

Elsevier

Access to resources Recommend Favorite

Opioids for chronic noncancer pain

Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite